Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Embolism | 102 | 2024 | 2370 | 16.130 |
Why?
|
Fibrin Fibrinogen Degradation Products | 20 | 2023 | 425 | 4.630 |
Why?
|
Venous Thromboembolism | 30 | 2022 | 1668 | 4.440 |
Why?
|
Patient Care Team | 13 | 2023 | 2527 | 2.490 |
Why?
|
Thrombolytic Therapy | 20 | 2024 | 2161 | 2.470 |
Why?
|
Ventricular Dysfunction, Right | 11 | 2021 | 578 | 2.350 |
Why?
|
Emergency Service, Hospital | 34 | 2021 | 7645 | 1.890 |
Why?
|
Anticoagulants | 17 | 2021 | 4595 | 1.730 |
Why?
|
Venous Thrombosis | 13 | 2021 | 1237 | 1.680 |
Why?
|
Fibrinolytic Agents | 9 | 2024 | 2156 | 1.200 |
Why?
|
Pulmonary Artery | 6 | 2021 | 1911 | 1.030 |
Why?
|
Acute Disease | 16 | 2023 | 7141 | 0.860 |
Why?
|
Clinical Protocols | 3 | 2018 | 1459 | 0.840 |
Why?
|
Ventricular Pressure | 2 | 2019 | 199 | 0.790 |
Why?
|
Embolectomy | 4 | 2019 | 120 | 0.790 |
Why?
|
Thrombectomy | 6 | 2021 | 679 | 0.780 |
Why?
|
Vena Cava Filters | 4 | 2020 | 252 | 0.780 |
Why?
|
Decision Support Techniques | 7 | 2019 | 1952 | 0.730 |
Why?
|
Hospital Rapid Response Team | 2 | 2018 | 57 | 0.720 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2020 | 1348 | 0.710 |
Why?
|
Tissue Plasminogen Activator | 5 | 2017 | 1262 | 0.710 |
Why?
|
Echocardiography | 14 | 2023 | 5097 | 0.710 |
Why?
|
Antifibrinolytic Agents | 3 | 2013 | 254 | 0.700 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 206 | 0.670 |
Why?
|
Middle Aged | 74 | 2022 | 213127 | 0.620 |
Why?
|
Humans | 142 | 2024 | 742088 | 0.580 |
Why?
|
Dextrocardia | 1 | 2016 | 37 | 0.580 |
Why?
|
Female | 92 | 2022 | 379592 | 0.560 |
Why?
|
Prospective Studies | 39 | 2022 | 53187 | 0.560 |
Why?
|
Probability | 8 | 2023 | 2502 | 0.560 |
Why?
|
Heparin | 3 | 2019 | 1636 | 0.560 |
Why?
|
Cardiac Output | 1 | 2019 | 853 | 0.560 |
Why?
|
Risk Assessment | 20 | 2020 | 23320 | 0.550 |
Why?
|
Predictive Value of Tests | 13 | 2018 | 15056 | 0.550 |
Why?
|
Renal Insufficiency | 1 | 2022 | 802 | 0.540 |
Why?
|
Emergency Treatment | 3 | 2018 | 517 | 0.530 |
Why?
|
Male | 86 | 2022 | 349538 | 0.520 |
Why?
|
Estrogen Replacement Therapy | 1 | 2022 | 1202 | 0.510 |
Why?
|
Flecainide | 1 | 2015 | 41 | 0.510 |
Why?
|
Radiation Injuries | 2 | 2013 | 1178 | 0.510 |
Why?
|
Aftercare | 2 | 2020 | 860 | 0.500 |
Why?
|
Intracranial Hemorrhages | 2 | 2017 | 854 | 0.500 |
Why?
|
Body Mass Index | 10 | 2022 | 12695 | 0.490 |
Why?
|
Angiography | 4 | 2015 | 1636 | 0.490 |
Why?
|
Genetic Predisposition to Disease | 10 | 2022 | 17400 | 0.490 |
Why?
|
Secondary Prevention | 1 | 2020 | 1520 | 0.480 |
Why?
|
Risk Factors | 33 | 2022 | 72145 | 0.470 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1199 | 0.450 |
Why?
|
Aged | 47 | 2022 | 162944 | 0.440 |
Why?
|
Adiposity | 2 | 2022 | 1806 | 0.430 |
Why?
|
Thrombosis | 3 | 2022 | 2966 | 0.430 |
Why?
|
Emergency Medicine | 6 | 2019 | 1205 | 0.420 |
Why?
|
Adult | 55 | 2022 | 213712 | 0.390 |
Why?
|
Metabolome | 1 | 2018 | 881 | 0.390 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15530 | 0.390 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1573 | 0.370 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 790 | 0.370 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 501 | 0.370 |
Why?
|
Sensitivity and Specificity | 12 | 2018 | 14720 | 0.370 |
Why?
|
Blood Coagulation | 1 | 2016 | 1126 | 0.370 |
Why?
|
Genome-Wide Association Study | 11 | 2022 | 12220 | 0.360 |
Why?
|
Electrocardiography | 4 | 2020 | 6440 | 0.360 |
Why?
|
Intubation, Intratracheal | 3 | 2020 | 1357 | 0.340 |
Why?
|
Delivery of Health Care | 2 | 2019 | 5304 | 0.340 |
Why?
|
Exercise | 3 | 2018 | 5611 | 0.340 |
Why?
|
Age Factors | 6 | 2018 | 18355 | 0.330 |
Why?
|
Treatment Outcome | 19 | 2024 | 62966 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 9 | 2018 | 20086 | 0.330 |
Why?
|
Ambulatory Care | 3 | 2022 | 2706 | 0.320 |
Why?
|
Paper | 1 | 2008 | 85 | 0.310 |
Why?
|
Outpatients | 5 | 2018 | 1483 | 0.310 |
Why?
|
Unnecessary Procedures | 3 | 2016 | 431 | 0.300 |
Why?
|
Hemorrhage | 6 | 2020 | 3461 | 0.300 |
Why?
|
Retrospective Studies | 18 | 2023 | 77098 | 0.300 |
Why?
|
Carnitine | 2 | 2018 | 239 | 0.300 |
Why?
|
Quality of Health Care | 2 | 2013 | 4369 | 0.290 |
Why?
|
Risk | 6 | 2017 | 9679 | 0.280 |
Why?
|
Patient Preference | 1 | 2013 | 886 | 0.280 |
Why?
|
Medical Audit | 1 | 2008 | 467 | 0.280 |
Why?
|
Arthritis, Infectious | 1 | 2010 | 367 | 0.280 |
Why?
|
Peptide Fragments | 2 | 2020 | 5095 | 0.280 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 12958 | 0.270 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7276 | 0.270 |
Why?
|
Computers, Handheld | 1 | 2008 | 208 | 0.270 |
Why?
|
Critical Care | 2 | 2020 | 2640 | 0.270 |
Why?
|
Heart Ventricles | 3 | 2023 | 3801 | 0.260 |
Why?
|
Heart Failure | 2 | 2023 | 10856 | 0.260 |
Why?
|
Libraries, Digital | 1 | 2005 | 6 | 0.260 |
Why?
|
Thromboembolism | 4 | 2020 | 983 | 0.260 |
Why?
|
Hospital Information Systems | 1 | 2008 | 395 | 0.260 |
Why?
|
Logistic Models | 11 | 2018 | 13403 | 0.260 |
Why?
|
Environmental Exposure | 2 | 2016 | 4231 | 0.250 |
Why?
|
Heart Arrest | 1 | 2015 | 1469 | 0.250 |
Why?
|
Hospitals, General | 3 | 2016 | 749 | 0.250 |
Why?
|
Resource Allocation | 2 | 2016 | 341 | 0.240 |
Why?
|
Mendelian Randomization Analysis | 2 | 2022 | 963 | 0.240 |
Why?
|
Sarcoptes scabiei | 1 | 2003 | 3 | 0.240 |
Why?
|
Hospitalization | 3 | 2020 | 10232 | 0.230 |
Why?
|
Decision Making | 2 | 2017 | 3869 | 0.230 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.230 |
Why?
|
Scabies | 1 | 2003 | 14 | 0.230 |
Why?
|
Risk Adjustment | 2 | 2021 | 594 | 0.220 |
Why?
|
Massachusetts | 4 | 2021 | 8662 | 0.210 |
Why?
|
Hypertension, Pulmonary | 4 | 2021 | 1527 | 0.210 |
Why?
|
Dyspnea | 4 | 2015 | 1298 | 0.200 |
Why?
|
Heart | 1 | 2015 | 4462 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1204 | 0.200 |
Why?
|
Systole | 1 | 2023 | 956 | 0.190 |
Why?
|
Diastole | 1 | 2023 | 791 | 0.190 |
Why?
|
Case-Control Studies | 8 | 2019 | 21719 | 0.190 |
Why?
|
Physicians | 1 | 2018 | 4554 | 0.180 |
Why?
|
Hospitals, Teaching | 2 | 2023 | 1179 | 0.180 |
Why?
|
Meningitis, Viral | 1 | 2019 | 50 | 0.180 |
Why?
|
Hypotension | 2 | 2016 | 880 | 0.170 |
Why?
|
Critical Illness | 3 | 2020 | 2665 | 0.170 |
Why?
|
Iopamidol | 1 | 2019 | 191 | 0.170 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13921 | 0.170 |
Why?
|
Fluid Therapy | 2 | 2020 | 592 | 0.170 |
Why?
|
Hemagglutination Tests | 1 | 2018 | 75 | 0.160 |
Why?
|
Exanthema | 1 | 2003 | 488 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 281 | 0.160 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3766 | 0.160 |
Why?
|
Diglycerides | 1 | 2018 | 176 | 0.160 |
Why?
|
Hypoxanthine | 1 | 2018 | 28 | 0.160 |
Why?
|
Radiography | 3 | 2014 | 7010 | 0.160 |
Why?
|
Tricarboxylic Acids | 1 | 2018 | 29 | 0.160 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39004 | 0.160 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 24 | 0.150 |
Why?
|
Standard of Care | 2 | 2018 | 562 | 0.150 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 363 | 0.150 |
Why?
|
Biomedical Research | 2 | 2016 | 3306 | 0.150 |
Why?
|
Inosine | 1 | 2018 | 133 | 0.150 |
Why?
|
Herpes Zoster | 1 | 2019 | 264 | 0.150 |
Why?
|
Odds Ratio | 7 | 2019 | 9846 | 0.150 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 643 | 0.140 |
Why?
|
Hospitals, University | 1 | 2019 | 571 | 0.140 |
Why?
|
Oxygen | 4 | 2015 | 4169 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 524 | 0.140 |
Why?
|
Health Care Rationing | 2 | 2016 | 435 | 0.140 |
Why?
|
Primary Health Care | 1 | 2013 | 4551 | 0.140 |
Why?
|
Research Design | 6 | 2018 | 5979 | 0.140 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 436 | 0.140 |
Why?
|
Positive-Pressure Respiration | 1 | 2020 | 632 | 0.140 |
Why?
|
Judgment | 1 | 2018 | 281 | 0.140 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 923 | 0.140 |
Why?
|
Microarray Analysis | 1 | 2019 | 766 | 0.130 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2016 | 86 | 0.130 |
Why?
|
Porphyrins | 1 | 2018 | 348 | 0.130 |
Why?
|
Resuscitation | 1 | 2020 | 657 | 0.130 |
Why?
|
Ultrasonic Therapy | 1 | 2018 | 235 | 0.130 |
Why?
|
Alcohol Drinking | 2 | 2018 | 3957 | 0.130 |
Why?
|
Chest Pain | 3 | 2015 | 1113 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2022 | 15494 | 0.130 |
Why?
|
Research | 1 | 2024 | 1999 | 0.130 |
Why?
|
Sodium Bicarbonate | 1 | 2015 | 62 | 0.130 |
Why?
|
Incidental Findings | 1 | 2020 | 688 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12242 | 0.130 |
Why?
|
Academic Medical Centers | 3 | 2017 | 2749 | 0.130 |
Why?
|
Lactic Acid | 1 | 2020 | 1132 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1517 | 0.130 |
Why?
|
Point-of-Care Systems | 2 | 2020 | 1175 | 0.130 |
Why?
|
Tachycardia | 2 | 2015 | 620 | 0.130 |
Why?
|
Ventricular Function, Right | 4 | 2021 | 592 | 0.130 |
Why?
|
Biological Assay | 1 | 2018 | 652 | 0.130 |
Why?
|
Obesity | 5 | 2022 | 12705 | 0.120 |
Why?
|
Estrogens | 1 | 2022 | 1562 | 0.120 |
Why?
|
Purines | 1 | 2018 | 593 | 0.120 |
Why?
|
Exercise Tolerance | 2 | 2018 | 770 | 0.120 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2003 | 2231 | 0.120 |
Why?
|
Fibrinolysis | 1 | 2015 | 322 | 0.120 |
Why?
|
Patient Transfer | 1 | 2021 | 760 | 0.120 |
Why?
|
Aged, 80 and over | 10 | 2022 | 57683 | 0.120 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4929 | 0.120 |
Why?
|
United States | 19 | 2021 | 69693 | 0.120 |
Why?
|
Pulmonary Medicine | 1 | 2016 | 213 | 0.120 |
Why?
|
Hemoptysis | 1 | 2015 | 155 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2019 | 622 | 0.120 |
Why?
|
Cohort Studies | 7 | 2020 | 40450 | 0.110 |
Why?
|
Disease Progression | 3 | 2017 | 13256 | 0.110 |
Why?
|
Smoking | 4 | 2019 | 8969 | 0.110 |
Why?
|
Consciousness Disorders | 1 | 2017 | 418 | 0.110 |
Why?
|
Metabolomics | 2 | 2018 | 1467 | 0.110 |
Why?
|
Hematology | 1 | 2016 | 219 | 0.110 |
Why?
|
Postmenopause | 1 | 2022 | 2461 | 0.110 |
Why?
|
Education, Medical, Graduate | 1 | 2005 | 2283 | 0.110 |
Why?
|
Contraceptives, Oral | 1 | 2015 | 563 | 0.110 |
Why?
|
Catheterization | 1 | 2018 | 1468 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 409 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2022 | 2978 | 0.100 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2015 | 321 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1532 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2013 | 339 | 0.100 |
Why?
|
Lower Extremity | 2 | 2020 | 1151 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2128 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 429 | 0.100 |
Why?
|
Radiography, Thoracic | 1 | 2018 | 1265 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
Time Factors | 7 | 2018 | 40054 | 0.100 |
Why?
|
Prognosis | 3 | 2018 | 29010 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2019 | 1155 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1679 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2015 | 693 | 0.100 |
Why?
|
Young Adult | 8 | 2021 | 56350 | 0.090 |
Why?
|
Advanced Cardiac Life Support | 1 | 2011 | 70 | 0.090 |
Why?
|
Organizational Innovation | 1 | 2014 | 559 | 0.090 |
Why?
|
Health Resources | 1 | 2016 | 911 | 0.090 |
Why?
|
Exercise Test | 1 | 2018 | 2075 | 0.090 |
Why?
|
Algorithms | 4 | 2023 | 13853 | 0.090 |
Why?
|
ROC Curve | 2 | 2016 | 3528 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2572 | 0.090 |
Why?
|
Length of Stay | 3 | 2021 | 6294 | 0.090 |
Why?
|
Fatty Acids | 1 | 2018 | 1806 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3862 | 0.090 |
Why?
|
Quality of Life | 6 | 2018 | 12730 | 0.090 |
Why?
|
Blood Sedimentation | 1 | 2010 | 231 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2059 | 0.090 |
Why?
|
Contrast Media | 2 | 2021 | 5295 | 0.090 |
Why?
|
Thoracic Surgery | 1 | 2016 | 713 | 0.090 |
Why?
|
Clinical Competence | 1 | 2005 | 4681 | 0.090 |
Why?
|
Membrane Transport Proteins | 1 | 2015 | 1028 | 0.080 |
Why?
|
Alleles | 2 | 2019 | 6931 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2282 | 0.080 |
Why?
|
ABO Blood-Group System | 1 | 2010 | 367 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2400 | 0.080 |
Why?
|
Patient Discharge | 2 | 2018 | 3300 | 0.080 |
Why?
|
Quality Improvement | 2 | 2014 | 3738 | 0.080 |
Why?
|
Internship and Residency | 2 | 2005 | 5774 | 0.080 |
Why?
|
Immobilization | 1 | 2009 | 236 | 0.080 |
Why?
|
Time and Motion Studies | 1 | 2008 | 149 | 0.080 |
Why?
|
Models, Genetic | 1 | 2018 | 3493 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1369 | 0.070 |
Why?
|
Overweight | 1 | 2018 | 2366 | 0.070 |
Why?
|
Accidental Falls | 1 | 2015 | 1057 | 0.070 |
Why?
|
Protective Clothing | 1 | 2007 | 102 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2450 | 0.070 |
Why?
|
Food | 1 | 2011 | 769 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2008 | 512 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10392 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.070 |
Why?
|
Ultrasonography | 2 | 2020 | 5978 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2451 | 0.070 |
Why?
|
Pericarditis, Constrictive | 1 | 2005 | 42 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 783 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2019 | 1973 | 0.070 |
Why?
|
Pericardiectomy | 1 | 2005 | 45 | 0.070 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2566 | 0.070 |
Why?
|
Technology Assessment, Biomedical | 1 | 2008 | 307 | 0.070 |
Why?
|
Laryngoscopes | 1 | 2007 | 145 | 0.070 |
Why?
|
Sympathomimetics | 1 | 2005 | 57 | 0.060 |
Why?
|
Nasal Decongestants | 1 | 2005 | 28 | 0.060 |
Why?
|
Ephedrine | 1 | 2005 | 54 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 21596 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 841 | 0.060 |
Why?
|
Consensus | 3 | 2019 | 2935 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1658 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2018 | 12344 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.060 |
Why?
|
Pregnancy | 3 | 2015 | 29087 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 6078 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3769 | 0.060 |
Why?
|
Boston | 2 | 2008 | 9305 | 0.060 |
Why?
|
Leg | 1 | 2009 | 1110 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1239 | 0.060 |
Why?
|
Particulate Matter | 1 | 2015 | 2523 | 0.060 |
Why?
|
Ivermectin | 1 | 2003 | 42 | 0.060 |
Why?
|
Blood Pressure | 2 | 2021 | 8541 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1873 | 0.060 |
Why?
|
Altitude | 1 | 2004 | 161 | 0.060 |
Why?
|
Comorbidity | 4 | 2018 | 10372 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2008 | 719 | 0.050 |
Why?
|
Physical Exertion | 1 | 2005 | 695 | 0.050 |
Why?
|
Statistics as Topic | 1 | 2009 | 2372 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9826 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3507 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2004 | 183 | 0.050 |
Why?
|
Stroke Volume | 1 | 2015 | 4983 | 0.050 |
Why?
|
Radiology | 1 | 2016 | 2090 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6540 | 0.050 |
Why?
|
Bibliometrics | 1 | 2005 | 339 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1426 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2267 | 0.050 |
Why?
|
Survival Analysis | 2 | 2011 | 10248 | 0.050 |
Why?
|
Canada | 1 | 2005 | 2061 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2016 | 3584 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9941 | 0.040 |
Why?
|
Testosterone Congeners | 1 | 2019 | 62 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2011 | 3187 | 0.040 |
Why?
|
Internationality | 1 | 2005 | 1002 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 506 | 0.040 |
Why?
|
Acyclovir | 1 | 2019 | 272 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8333 | 0.040 |
Why?
|
Databases, Factual | 3 | 2021 | 7716 | 0.040 |
Why?
|
Motor Activity | 1 | 2009 | 2714 | 0.040 |
Why?
|
Iodine | 1 | 2021 | 285 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2016 | 4248 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 739 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2021 | 400 | 0.040 |
Why?
|
Genotype | 3 | 2019 | 12946 | 0.040 |
Why?
|
Patient Care Management | 1 | 2021 | 306 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10578 | 0.040 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2018 | 110 | 0.040 |
Why?
|
Convalescence | 1 | 2017 | 105 | 0.040 |
Why?
|
Recovery of Function | 2 | 2018 | 2924 | 0.040 |
Why?
|
Fetal Blood | 1 | 2004 | 1317 | 0.040 |
Why?
|
Cough | 1 | 2021 | 555 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 24913 | 0.040 |
Why?
|
Group Processes | 1 | 2018 | 225 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2008 | 2643 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2017 | 683 | 0.040 |
Why?
|
Postthrombotic Syndrome | 1 | 2016 | 28 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2005 | 1066 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 213 | 0.030 |
Why?
|
Sample Size | 1 | 2019 | 844 | 0.030 |
Why?
|
France | 1 | 2016 | 517 | 0.030 |
Why?
|
American Heart Association | 1 | 2019 | 1055 | 0.030 |
Why?
|
Pilot Projects | 1 | 2008 | 8297 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2015 | 0.030 |
Why?
|
Anemia | 1 | 2004 | 1499 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6454 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2016 | 438 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1589 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2018 | 934 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2010 | 2970 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2020 | 1059 | 0.030 |
Why?
|
Diet | 1 | 2011 | 7923 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 2016 | 550 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1612 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 574 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15108 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2015 | 499 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1653 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 85649 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3587 | 0.030 |
Why?
|
Shock | 1 | 2014 | 318 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1869 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2015 | 976 | 0.020 |
Why?
|
Particle Size | 1 | 2015 | 1640 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1581 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3510 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8626 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11690 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2014 | 12017 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1499 | 0.020 |
Why?
|
Medicare | 2 | 2018 | 6532 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2017 | 1368 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 939 | 0.020 |
Why?
|
Medicine | 1 | 2017 | 941 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 20928 | 0.020 |
Why?
|
Bundle-Branch Block | 1 | 2009 | 270 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3527 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3656 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4214 | 0.020 |
Why?
|
Thrombophilia | 1 | 2010 | 305 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5310 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2008 | 587 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2495 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5692 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6452 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 1003 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 2866 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8077 | 0.020 |
Why?
|
Mortality | 1 | 2016 | 2857 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1914 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4030 | 0.020 |
Why?
|
Coronary Vasospasm | 1 | 2005 | 88 | 0.020 |
Why?
|
Nonprescription Drugs | 1 | 2005 | 116 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 25575 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168561 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6483 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6575 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2021 | 3130 | 0.010 |
Why?
|
Travel | 1 | 2009 | 788 | 0.010 |
Why?
|
Hematocrit | 1 | 2004 | 636 | 0.010 |
Why?
|
Prevalence | 2 | 2012 | 15194 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21821 | 0.010 |
Why?
|
Air Pollution | 1 | 2015 | 2284 | 0.010 |
Why?
|
Peru | 1 | 2004 | 881 | 0.010 |
Why?
|
Acetaminophen | 1 | 2005 | 544 | 0.010 |
Why?
|
Oximetry | 1 | 2004 | 467 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5724 | 0.010 |
Why?
|
Warfarin | 1 | 2008 | 1493 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.010 |
Why?
|
Drug Combinations | 1 | 2005 | 1961 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16331 | 0.010 |
Why?
|
Respiration | 1 | 2004 | 1645 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2005 | 2303 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81045 | 0.010 |
Why?
|
Public Health | 1 | 2005 | 2594 | 0.010 |
Why?
|
Curriculum | 1 | 2005 | 3589 | 0.010 |
Why?
|